Respiratory COPD Exacerbation

Assess severity & predict acute COPD exacerbation outcome with BAP-65 and DECAF

"Respiratory COPD Exacerbation: BAP65 & DECAF Score" is a mobile app designed to help with health practitioner in assessing the severity and predicting the outcome in acute exacerbation of chronic obstructive pulmonary disease (COPD) by using BAP-65 and DECAF Score. Chronic obstructive pulmonary disease (COPD) is defined as a common preventable and treatable disease, characterised by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients.

There are several features of "Respiratory COPD Exacerbation: BAP65 & DECAF Score", namely:

🔸 Simple and very easy to use COPD app.

🔸 Precise calculation and classification with BAP-65 score.

🔸 Easy calculation and interpretation of DECAF score.

🔸 Assess severity and predict outcome of acute COPD exacerbation.

🔸 It is totally free. Download now!

Both BAP-65 and DECAF score in "Respiratory COPD Exacerbation: BAP65 & DECAF Score" app correlates well with both in-hospital mortality and need for mechanical ventilation in patients with COPD. The BAP-65 system is a score composed of 4 variables. All of them are available upon presentation to the hospital. The B letter stands for Blood Urea Nitrogen (BUN) and it is positive if level is above 25 mg/dL. The A letter stands for Altered Mental Status and it is counted positive when the initial Glasgow Coma Scale (GCS) is 14 or less, or when the physician has designated that the patient was disoriented, stuporous or in coma. The P letter stands for Pulse and it is positive when the initial pulse is above 109 beats/min. Finally, an additional point will be added if the patient was above 65 years old.

While DECAF score is a simple, reliable, accurate prediction tool could potentially improve patient care, by identifying patients suitable for hospital discharge or for more intensive therapy / monitoring. DECAF is simple to calculate and apply at the bedside. It requires an assessment of the patient’s usual level of breathlessness and function: the eMRCD score.

Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Respiratory COPD Exacerbation: BAP65 & DECAF Score" app might be different with your local practice. Consult to expert doctor whenever necessary.